Global Post-Authorization Safety Surveillance Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Global Post-Authorization Safety Surveillance Study

Published:2016-07 Issue:5 Volume:27 Page:551-556
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Negrier Claude,Voisin Sophie,Baghaei Fariba,Numerof Robert,Novack Aaron,Doralt Jennifer E.,Romanov Vadim,Gringeri Alessandro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference20 articles.

1. FEIBA versus NovoSeven in hemophilia patients with inhibitors;Franchini;Semin Thromb Hemost,2013

2. Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies;Coppola;Haemophilia,2010

3. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction;Leissinger;Am J Hematol,2004

4. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors;Konkle;J Thromb Haemost,2007

5. The principal results of the International Immune Tolerance Study: a randomized dose comparison;Hay;Blood,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors;TH Open;2024-07

2. A Post-Authorization Safety Surveillance Study to Report Clinical Experience with Purified Factor IX Concentrate in Pediatric Patients with Hemophilia B;Journal of Blood Medicine;2024-03

3. Regular prophylaxis with activated prothrombin complex concentrates in pediatric hemophilia;Pediatrics International;2024-01

4. Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study;Therapeutic Advances in Hematology;2023-01

5. Inhibitors in Hemophilia B;Advances in Hemophilia Treatment;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3